J. Nowicka

Discovery and Pharmacokinetics of Sulfamides and Guanidines as Potent Human Arginase 1 Inhibitors.

J. Gołąb, K. Dzwonek, A. Gołębiowski, 2020, ACS medicinal chemistry letters.

OATD-02 Validates the Benefits of Pharmacological Inhibition of Arginase 1 and 2 in Cancer

P. Dobrzanski, Bartłomiej Borek, K. Dzwonek, 2022, Cancers.

Targeting ARG2 as a novel therapeutic approach for cancer

P. Dobrzanski, Bartłomiej Borek, K. Dzwonek, 2019, Annals of Oncology.

Arginase 1/2 inhibitor OATD-02: from discovery to first-in-man setup in cancer immunotherapy.

J. Gołąb, P. Dobrzanski, P. Iwanowski, 2023, Molecular cancer therapeutics.

Comparative analysis of RNA 3D structure prediction methods: towards enhanced modeling of RNA–ligand interactions

C. Nithin, J. Nowicka, S. Kmiecik, 2024, Nucleic acids research.